Actinium Pharmaceuticals, Inc. (ATNM)
SG&A Expense Growth
20.92%
Quarterly · Period ending:
ATNM SG&A Expense Growth
Latest reported20.92%period ending
Latest reported20.92%period ending
ATNM Quarterly SG&A Growth (QoQ) (0.00% → 20.92%)
Latest values, visible window
High-resolution chart · PNG
ATNM sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 20.9166% | |
| -19.6032% | |
| 38.0052% | |
| -41.5396% | |
| -70.6422% | |
| 231.7743% | |
| -4.7046% | |
| -21.3192% | |
| 21.3032% | |
| 28.4475% | |
| -15.5002% | |
| -40.1666% | |
| 22.1151% | |
| -5.6342% | |
| 28.7992% | |
| -4.949% | |
| 86.3401% | |
| -34.6516% | |
| 33.1494% | |
| 16.6082% | |
| -0.4657% | |
| -4.343% | |
| -1.589% | |
| 58.1456% | |
| -24.6736% | |
| 32.5886% | |
| -36.618% | |
| 69.2665% | |
| -20.9831% | |
| 3.5714% | |
| -32.9598% | |
| 24.6349% | |
| -16.1788% | |
| 40.3286% | |
| -22.4667% | |
| -38.5409% | |
| -14.3293% | |
| 12.9088% | |
| 108.2437% | |
| -49.2727% | |
| 23.9856% | |
| -4.1072% | |
| 28.8579% | |
| -49.4366% | |
| -6.7262% | |
| 34.6304% | |
| -13.2023% | |
| 34.8654% | |
| 44.0931% | |
| 40.9588% | |
| 43.1271% | |
| -14.0358% | |
| 3.5613% | |
| -79.2314% | |
| 522.2673% | |
| 203.4942% | |
| 3,110.6343% | |
| 402.3729% | |
| -39.3004% | |
| -24.8841% | |
| 30.7071% | |
| -65.7913% | |
| -7.5045% | |
| 60.3526% | |
| -10.8227% | |
| -21.2723% | |
| 231.8052% | |
| 6.079% | |
| -43.9045% | |
| -41.3891% | |
| 186.724% | |
| -73.6073% | |
| 175.104% | |
| -27.7012% | |
| -4.615% | |
| 47.2535% | |
| 0% | |
| -100% | |
| -25.1844% | |
| 0% |